跳至主要内容
临床试验/ISRCTN00157697
ISRCTN00157697已完成不适用

The clinical and economic effectiveness of high-dose aprotinin and tranexamic acid in patients undergoing first time open-heart surgery: a single-centre, double blind, prospective, randomised, placebo-controlled trial

eiden University Medical Centre (LUMC) (Netherlands)0 个研究点目标入组 300 人开始时间: 2005年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients scheduled for first time, non-complex (one or two procedures) open heart surgery with the use of Cardiopulmonary Bypass (CPB).

排除标准

  • 1. Less than 18 years old
  • 2. Previous sternotomy
  • 3. Previous aprotinin therapy
  • 4. Known or suspected allergy to aprotinin
  • 5. Refusal to receive blood transfusion
  • 6. Abnormal perioperative coagulation profile for reasons other than anticoagulant therapy
  • 7. Treatment with antiplatelet agents within five days of the operation
  • 8. Known bleeding disorder
  • 9. Pregnancy
  • 10. Scheduled for three or more procedures
  • 11. Emergency operations

研究者

发起方
eiden University Medical Centre (LUMC) (Netherlands)

相似试验